Study of QLS5308 in Patients With Advanced Solid Tumors

NCT07462442 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Solid Tumors

Interventions

DRUG: QLS5308 IV infusion

Sponsor

Qilu Pharmaceutical Co., Ltd.